Invariant NKT cells amplify the innate immune response to lipopolysaccharide

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 2706-2713

  Nagarajan, Niranjana A ^b   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; INNATE IMMUNITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 33847361128     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.5.2706     Document Type: Article

References (39)

1. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
2. Yu, K. O., and S. A. Porcelli. 2005. The diverse functions of CD Id-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100: 42-55.
3. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
4. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
5. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
6. Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M. R. Benhnia, D. M. Zajonc, G. Ben-Menachem, G. D. Ainge, G. F. Painter, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7: 978-986.
7. Fitzgerald, K. A., D. C. Rowe, and D. T. Golenbock. 2004. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect. 6: 1361-1367.
8. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
9. Annane, D., E. Bellissant, and J. M. Cavaillon. 2005. Septic shock. Lancet 365: 63-64.
10. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J. Immunol. 160: 3522-3527.
11. Dieli, F., G. Sireci, D. Russo, M. Taniguchi, J. Ivanyi, C. Femandez, M. Troye-Blomberg, G. De Leo, and A. Salerno. 2000. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J. Exp. Med. 192: 1645-1652.
12. +NKT cells in lipopolysaccharide-induced lethal shock in mice. J. Immunol. 169: 1426-1432.
13. Shimizu, H., T. Matsuguchi, Y. Fukuda, I. Nakano, T. Hayakawa, O. Takeuchi, S. Akira, M. Umemura, T. Suda, and Y. Yoshikai. 2002. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123: 1265-1277.
14. Hiromatsu, T., T. Matsuguchi, H. Shimizu, T. Yajima, H. Nishimura, T. Arai, Y. Nimura, and Y. Yoshikai. 2003. NK T cells stimulated with a ligand for TLR2 at least partly contribute to liver injury caused by Escherichia coli infection in mice. Eur. J. Immunol. 33: 2511-2519.
15. + NKT cells to initiate contact sensitivity in vivo. J. Immunol. 175: 6390-6401.
16. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
17. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayarna, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
18. Motoki, K., M. Morita, E. Kobayashi, T. Uchida, K. Akimota.H. Fukushima, and Y. Koezuka. 1995. Immunostimulatory and antitumor activities of monoglyco-sylceramides having various sugar moieties. Biol. Pharm. Ball. 18: 1487-1491.
19. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38: 2176-2187.
20. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol Methods 223: 77-92.
21. Leite-De-Moraes, M. C., A. Hameg, A. Arnould, F. Machavoine, Y. Koezuka, E. Schneider, A. Herbelin and M. Dy. 1999. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J. Immunol 163: 5871-5876.
22. Nakahira, M., H. J. Ahn, W. R. Park, P. Gao, M. Tomura, C. S. Park, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara. 2002. Synergy of IL-12 and IL-18 for IFN-α gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein I. J. Immunol. 168: 1146-1153.
23. Robinson, D. S., and A. O'Garra. 2002. Further checkpoints in Th1 development. Immunity 16: 755-758.
24. + T cells provide an early source of IFN-γ J. Immunol. 170: 2399-2408.
25. Terabe, M., J. Swann, E. Ambrosino, P. Sinha, S. Takaku, Y. Hayakawa, D. I. Godfrey, S. Ostrand-Rosenberg, M. J. Smyth, and J. A. Berzofsky. 2005. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202: 1627-1633.
26. Park, S. H., T. Kyin, A. Bendelac, and C. Carnaud. 2003. The contribution of NKT cells, NK cells, and other γ-chain-dependent non-T non-B cells to IL-12-mediated rejection of tumors. J. Immunol. 170: 1197-1201.
27. Varma, T. K., C. Y. Lin, T. E. Toliver-Kinsky, and E. R. Sherwood. 2002. Endotoxin-induced γ interferon production: contributing cell types and key regulatory factors. Clin. Diagn. Lab. Immunol. 9: 530-543.
28. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650.
29. Matsuda, J. L., L. Gapin, J. L. Baron, S. Sidobre, D. B. Stetson, M. Mohrs, R. M. Locksley, and M. Kronenberg. 2003. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100: 8395-8400.
30. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99: 1259-1266.
31. Grivennikov, S. I., A. V. Tumanov, D. J. Liepinsh, A. A. Kruglov, B. I. Marakusha, A. N. Shakhov, T. Murakami, L. N. Drutskaya, I. Forster, B. E. Clausen, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22: 93-104.
32. Koemer, T. J., D. O. Adams, and T. A. Hamilton. 1987. Regulation of tumor necrosis factor (TNF) expression: interferon-γ enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell. Immunol. 109: 437-443.
33. Donnelly, R. P., S. L. Freeman, and M. P. Hayes. 1995. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J. Immunol. 155: 1420-1427.
34. Hayes, M. P., S. L. Freeman, and R. P. Donnelly. 1995. IFN-α priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine 7; 427-435.
35. + T cells upon NK T or T cell activation. J. Immunol. 165: 4305-4311.
36. Zhou, D., J. Mattner, C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
37. Mallevaey, T., J. P. Zanetta, C. Faveeuw, J. Fontaine, E. Maes, F. Platt, M. Capron, M. L. de-Moraes, and F. Trottein. 2006. Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni. J. Immunol. 176: 2476-2485.
38. Skold, M., X. Xiong, P. A. Illarionov, G. S. Besra, and S. M. Behar. 2005. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J. Immunol. 175: 3584-3593.
39. Ito, H., N. Koide, F. Hassan, S. Islam, G. Tumurkhuu, I. Mori, T. Yoshida, S. Kakumu, H. Moriwaki, and T. Yokochi. 2006. Lethal endotoxic shock using α-galactosylceramide sensitization as a new experimental model of septic shock. Lab. Invest. 86: 254-261.